Xenetic Biosciences, Inc. Share Price

Xenetic Biosciences, Inc. Share Price

NASDAQ: XBIO
$0.00
+0.00 (0.00%)
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Xenetic Biosciences, Inc. Stock Performance

Open
N/A
Prev. Close
N/A
Circuit Range
N/A
Day Range
N/A
Year Range
$1.71 - $4.80
Volume
N/A
Average Traded
N/A

Xenetic Biosciences, Inc. Share Price Chart

Line chart of the Xenetic Biosciences, Inc. price trend over the selected period. The price rose overall, ranging from 1.71 to 1.71, ending at 1.71.
$0.00$0.00
L
Show Current Price
H

Xenetic Biosciences, Inc. Stock Fundamentals & Key Indicators

Market Cap
N/A
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-1.56
Revenue (TTM)
$0.00
Return On Equity (TTM)
-82.94%
Profit Margin
N/A
Debt to Equity
0.00
Quarterly Earnings Growth YoY
-193.10%

Xenetic Biosciences, Inc. Quarterly Profit & Loss

All figures in USD

ParticularsDec 2025Mar 2026Jun 2026Sep 2026
Revenue$0.00$0.81$0.66$0.73
Net Profit-$0.58-$0.46-$0.93-$1.70
Net Profit MarginN/A-56.79%-140.91%-232.88%
Income ChangeN/A20.69%-102.17%-82.80%

Xenetic Biosciences, Inc. Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$0.00$2.54$0.00$0.00
Net Profit-$6.55-$4.13-$3.96-$2.68
Net Profit MarginN/A-162.60%N/AN/A
Income ChangeN/A36.95%4.12%32.32%

About Xenetic Biosciences, Inc.

Xenetic Biosciences Inc is a biopharmaceutical company focused on advancing immuno-oncology technologies addressing difficult-to-treat cancers. The company's DNase technology is designed to improve outcomes of existing treatments, including immunotherapies, by targeting neutrophil extracellular traps (NETs), which are involved in the progression of many human cancers. Xenetic is also focused on advancing its systemic DNase program into the clinic as an adjunctive therapy for pancreatic carcinoma and other locally metastatic solid tumors. Its product pipeline consists of two key programs, XBIO-015 and XBIO-020, which are being developed to address pancreatic carcinoma and solid tumours.

Xenetic Biosciences, Inc. Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Nov 2026
$2.12
$1.71
-14.50%
Oct 2026
$2.25
$2.00
-10.31%
Sep 2026
$4.43
$2.23
-42.00%
Aug 2026
$2.75
$3.85
+45.64%
Jul 2026
$2.85
$2.64
-12.29%
Jun 2026
$3.14
$3.01
-3.83%
May 2026
$3.15
$3.13
+1.29%
Apr 2026
$2.98
$3.09
+13.19%
Mar 2026
$2.52
$2.73
+13.75%
Feb 2026
$2.25
$2.40
+5.73%
Jan 2026
$2.15
$2.27
+6.57%
Dec 2025
$2.50
$2.13
-21.11%

XBIO Share Price FAQs